Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use. Havrdova E, Horakova D, Kovarova I Ther Adv Neurol Disord. 2015 Jan; 8(1):31-45. PMID: 25584072. Abstract CommentRecommendBookmarkWatch